APA (7th ed.) Citation

Padden-Modi, M., Spivak, Y., Gleeson, I., Robinson, A., & Thippu Jayaprakash, K. (2022). PO-1242 Clinical, pathological and dosimetric factors influencing outcomes in NSCLC treated with SABR. Radiotherapy & Oncology, 170, S1048. https://doi.org/10.1016/S0167-8140(22)03206-6

Chicago Style (17th ed.) Citation

Padden-Modi, M., Y. Spivak, I. Gleeson, A. Robinson, and K. Thippu Jayaprakash. "PO-1242 Clinical, Pathological and Dosimetric Factors Influencing Outcomes in NSCLC Treated with SABR." Radiotherapy & Oncology 170 (2022): S1048. https://doi.org/10.1016/S0167-8140(22)03206-6.

MLA (9th ed.) Citation

Padden-Modi, M., et al. "PO-1242 Clinical, Pathological and Dosimetric Factors Influencing Outcomes in NSCLC Treated with SABR." Radiotherapy & Oncology, vol. 170, 2022, p. S1048, https://doi.org/10.1016/S0167-8140(22)03206-6.